Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Myeloid Hematologic Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT01362179
What this trial is testing

National Marrow Donor Program Long-Term Donor Follow-Up

Who this might be right for
Hematologic Neoplasms
Center for International Blood and Marrow Transplant Research 21,974
Testing effectiveness (Phase 2)Study completedNCT01830361
What this trial is testing

Trial to Assess the Efficacy of Midostaurin (PKC412) in Patients With c-KIT or FLT3-ITD Mutated t(8;21) AML

Who this might be right for
Acute Myeloid Leukemia
Technische Universität Dresden 18
Testing effectiveness (Phase 2)Looking for participantsNCT07392242
What this trial is testing

The Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Memorial Sloan Kettering Cancer Center 45
Testing effectiveness (Phase 2)Study completedNCT00005854
What this trial is testing

Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more
Fred Hutchinson Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Not applicableEnded earlyNCT03549351
What this trial is testing

Evaluation of Measurable Residual Disease in Patients With Acute Myeloid Leukemia as Surrogate Endpoint for Survival

Who this might be right for
Leukemia, Myeloid, Acute
University Hospital Heidelberg 51
Not applicableActive Not RecruitingNCT06092879
What this trial is testing

Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France

Who this might be right for
Chronic Myeloid Leukemia
Novartis Pharmaceuticals 201
Large-scale testing (Phase 3)Study completedNCT00514488
What this trial is testing

Imatinib Standard Dose (400 mg/Day) Versus Imatinib High Dose (800 mg/Day)

Who this might be right for
Chronic Myeloid Leukemia
University of Bologna
Early research (Phase 1)Looking for participantsNCT07723703
What this trial is testing

Phase 1 Open-label Study of AMX-883 Alone in Participants With AML and High-risk MDS and in Combination in Participants With AML

Who this might be right for
Acute Myeloid LeukaemiaHigh Risk Myelodysplastic Syndrome
Amphista Therapeutics Ltd 54
Early research (Phase 1)Ended earlyNCT00577694
What this trial is testing

Clofarabine and Gemtuzumab in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Leukemia
UNC Lineberger Comprehensive Cancer Center 21
Testing effectiveness (Phase 2)WithdrawnNCT03739606
What this trial is testing

Flotetuzumab in Treating Patients With Recurrent or Refractory CD123 Positive Blood Cancer

Who this might be right for
Acute Biphenotypic LeukemiaAcute LeukemiaChronic Myelogenous Leukemia, BCR-ABL1 Positive+12 more
City of Hope Medical Center
Early research (Phase 1)Ended earlyNCT00430443
What this trial is testing

Liposomal Annamycin in Children and Young Adults With Refractory or Relapsed ALL or AML

Who this might be right for
Acute Lymphocytic LeukemiaAcute Myelogenous Leukemia
Callisto Pharmaceuticals 3
Large-scale testing (Phase 3)Study completedNCT04666259
What this trial is testing

Asciminib in Monotherapy for Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without T315I Mutation

Who this might be right for
Chronic Myelogenous Leukemia - Chronic Phase
Novartis Pharmaceuticals 56
Testing effectiveness (Phase 2)WithdrawnNCT01835288
What this trial is testing

Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Adult Acute Megakaryoblastic Leukemia (M7)Adult Acute Minimally Differentiated Myeloid Leukemia (M0)Adult Acute Monoblastic Leukemia (M5a)+12 more
Stanford University
Testing effectiveness (Phase 2)Study completedNCT00482703
What this trial is testing

Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia

Who this might be right for
Myeloid Leukemia, Chronic
Bristol-Myers Squibb 23
Early research (Phase 1)UnknownNCT01619761
What this trial is testing

NK Cells in Cord Blood Transplantation

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAcute Biphenotypic LeukemiaAcute Lymphoblastic Leukemia in Remission+22 more
M.D. Anderson Cancer Center 13
Early research (Phase 1)Looking for participantsNCT06763341
What this trial is testing

AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
Recurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
City of Hope Medical Center 12
Testing effectiveness (Phase 2)Study completedNCT00004061
What this trial is testing

Biological Therapy in Treating Patients Undergoing Radiation Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation for Hematologic Cancer

Who this might be right for
LeukemiaLymphomaOral Complications
Memorial Sloan Kettering Cancer Center 111
Early research (Phase 1)Study completedNCT01256073
What this trial is testing

A Safety and Tolerability Extension Trial Assessing Repeated Dosing of Anti-KIR (1-7F9) Human Monoclonal Antibody in Patients With Acute Myeloid Leukaemia

Who this might be right for
Acute Myeloid Leukemia
Innate Pharma 21
Testing effectiveness (Phase 2)Study completedNCT01266083
What this trial is testing

WT1 Vaccine Treatment of Patients in Remission From Acute Myeloid Leukemia (AML) or Acute Lymphoblastic Leukemia (ALL)

Who this might be right for
Acute Myeloid LeukemiaAcute Lymphoblastic Leukemia
Sellas Life Sciences Group 22
Next Page